{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T14:37:40Z","timestamp":1785595060329,"version":"3.56.0"},"reference-count":80,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"International Medical University (IMU)'s Institute for Research, Development and Innovation (IRDI)","award":["MPP 1\/2020 (04)"],"award-info":[{"award-number":["MPP 1\/2020 (04)"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>The objective of this study was to assess the comparative efficacy and safety of different antifungal agents used for the treatment of oropharyngeal candidiasis (OPC) in adult patients with HIV. A systematic search was performed on the four major databases (Medline, Embase, CENTRAL and Scopus) to identify randomized controlled trials (RCTs) that evaluated the efficacy of antifungal agents in HIV patients with OPC. A network meta-analysis was performed from the data extracted from the selected studies. The agents were ranked according using surface under the cumulative ranking (SUCRA). The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach was used to determine the quality of evidence. A total of 15 trials were included in the quantitative analysis involving the data from a total of 2883 participants. Fluconazole was ranked as the most effective antifungal agent to achieve clinical cure (SUCRA = 0.87) in OPC followed by posaconazole and itraconazole. Posaconazole was ranked the most efficacious agent in achieving mycological cure (SUCRA = 0.81), followed by fluconazole. While nystatin was ranked the safest, the effect estimates of none of the other systemic antifungal agents were significantly higher than fluconazole. Based on the available evidence, fluconazole can be considered as the most effective drug in the treatment of OPC among HIV-infected adults and has a favorable safety profile, followed by posaconazole.<\/jats:p>","DOI":"10.3390\/jof7080637","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T09:35:32Z","timestamp":1628156132000},"page":"637","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Comparative Efficacy of Antifungal Agents Used in the Treatment of Oropharyngeal Candidiasis among HIV-Infected Adults: A Systematic Review and Network Meta-Analysis"],"prefix":"10.3390","volume":"7","author":[{"given":"Shamala Gopal","family":"Rajadurai","sequence":"first","affiliation":[{"name":"School of Postgraduate Studies, International Medical University, Kuala Lumpur 57000, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6812-0533","authenticated-orcid":false,"given":"Mari Kannan","family":"Maharajan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, School of Pharmacy, International Medical University, Kuala Lumpur 57000, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajesh K.","family":"Veettil","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT 84112, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4279-7420","authenticated-orcid":false,"given":"Divya","family":"Gopinath","sequence":"additional","affiliation":[{"name":"Clinical Oral Health Sciences, International Medical University, Kuala Lumpur 57000, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1600-0714.1989.tb01552.x","article-title":"Oral candidiasis and human immunodeficiency virus infection","volume":"18","author":"Samaranayake","year":"1989","journal-title":"J. Oral Pathol. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0030-4220(92)90191-R","article-title":"Oral mycoses in HIV infection","volume":"73","author":"Samaranayake","year":"1992","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1128\/CMR.17.4.729-759.2004","article-title":"Immunopathogenesis of Oropharyngeal Candidiasis in Human Immunodeficiency Virus Infection","volume":"17","author":"Lewandowski","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/154407370601900126","article-title":"(B3) Markers of Immunodeficiency and Mechanisms of HAART Therapy on Oral Lesions","volume":"19","author":"Flint","year":"2006","journal-title":"Adv. Dent. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1601-0825.2003.00994.x","article-title":"Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients. A Greek study","volume":"10","author":"Velegraki","year":"2004","journal-title":"Oral Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/cid\/ciw125","article-title":"Incidence of Opportunistic Infections and the Impact of Antiretroviral Therapy Among HIV-Infected Adults in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis","volume":"62","author":"Low","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.tripleo.2007.12.024","article-title":"Do oral lesions associated with HIV affect quality of life?","volume":"106","author":"Yengopal","year":"2008","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.tripleo.2009.11.026","article-title":"Oropharyngeal candidiasis in the era of antiretroviral therapy","volume":"109","author":"Thompson","year":"2010","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol."},{"key":"ref_9","first-page":"48","article-title":"Oral candida in Mexican children with malnutrition, social marginalization, or HIV\/AIDS","volume":"31","year":"2012","journal-title":"Rev. Panam. De Salud P\u00fabli."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1086\/516315","article-title":"Oropharyngeal and Esophageal Candidiasis in Immunocompromised Patients: Treatment Issues","volume":"26","author":"Darouiche","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.7326\/0003-4819-104-1-54","article-title":"Oral Candidiasis as a Marker for Esophageal Candidiasis in the Acquired Immunodeficiency Syndrome","volume":"104","author":"Tavitian","year":"1986","journal-title":"Ann. Intern. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/01.qai.0000226334.34717.dc","article-title":"Determinants of Survival Without Antiretroviral Therapy After Infancy in HIV-1-Infected Zambian Children in the CHAP Trial","volume":"42","author":"Walker","year":"2006","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/AAC.34.11.2267","article-title":"Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus","volume":"34","author":"Koletar","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1754-4505.1992.tb00402.x","article-title":"A comparison between fluconazole tablets and clotrimazole troches for the treatment of thrush in HIV infection","volume":"12","author":"Redding","year":"1992","journal-title":"Sp\u00e9c. Care Dent."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0002-9343(97)00307-0","article-title":"Randomized Trial of Itraconazole Oral Solution for Oropharyngeal Candidiasis in HIV\/AIDS Patients","volume":"104","author":"Graybill","year":"1998","journal-title":"Am. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000239469","article-title":"Comparison of Itraconazole and Ketoconazole in HIV-Positive Patients with Oropharyngeal or Esophageal Candidiasis","volume":"42","author":"Ratelle","year":"1996","journal-title":"Chemotherapy"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(89)92572-5","article-title":"Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS","volume":"333","author":"Goossens","year":"1989","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF01974616","article-title":"A Multicentre Study Group Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children","volume":"13","year":"1994","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Shen, L.Y., Yee, W.T., Veettil, S.K., Wong, P.S., Gopinath, D., Ching, M.S., and Menon, R.K. (2020). Antifungal agents in preventing oral candidiasis in clinical oncology: A network meta-analysis. Oral Dis.","DOI":"10.1111\/odi.13588"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1086\/501457","article-title":"A Multicenter Randomized Trial Evaluating Posaconazole versus Fluconazole for the Treatment of Oropharyngeal Candidiasis in Subjects with HIV\/AIDS","volume":"42","author":"Vazquez","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","article-title":"Simultaneous comparison of multiple treatments: Combining direct and indirect evidence","volume":"331","author":"Caldwell","year":"2005","journal-title":"BMJ"},{"key":"ref_22","unstructured":"(2020, December 26). Cochrane Handbook for Systematic Reviews of Interventions. Available online: https:\/\/training.cochrane.org\/handbook\/current."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-Analyses of Health Care Interventions: Checklist and Explanations","volume":"62","author":"Hutton","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","article-title":"Random-effects model for meta-analysis of clinical trials: An update","volume":"28","author":"DerSimonian","year":"2007","journal-title":"Contemp. Clin. Trials"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13643-017-0473-z","article-title":"Approaches to interpreting and choosing the best treatments in network meta-analyses","volume":"6","author":"Mbuagbaw","year":"2017","journal-title":"Syst. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jval.2011.01.011","article-title":"Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2","volume":"14","author":"Hoaglin","year":"2011","journal-title":"Value Health"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"N: Meta-Analysis in Clinical Trials","volume":"7","author":"Dersimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/ije\/dys222","article-title":"Evaluation of inconsistency in networks of interventions","volume":"42","author":"Veroniki","year":"2013","journal-title":"Int. J. Epidemiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: Concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Res. Synth. Methods"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: An overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Chaimani, A., Higgins, J., Mavridis, D., Spyridonos, P., and Salanti, G. (2013). Graphical Tools for Network Meta-Analysis in STATA. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076654"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"g5630","DOI":"10.1136\/bmj.g5630","article-title":"For the GRADE Working Group A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ"},{"key":"ref_35","first-page":"45","article-title":"Gentian violet, ketoconazole and nystatin in oropharyngeal and esophageal candidiasis in Zairian AIDS patients","volume":"72","author":"Nyst","year":"1992","journal-title":"Ann. Soc. Belg. Med. Trop."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1086\/511039","article-title":"Posaconazole for the Treatment of Azole-Refractory Oropharyngeal and Esophageal Candidiasis in Subjects with HIV Infection","volume":"44","author":"Skiest","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/AAC.46.2.451-457.2002","article-title":"Randomized, Double-Blind, Multicenter Study of Caspofungin versus Amphotericin B for Treatment of Oropharyngeal and Esophageal Candidiases","volume":"46","author":"Arathoon","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/bmj.305.6859.921","article-title":"Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis","volume":"305","author":"Chavanet","year":"1992","journal-title":"BMJ"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/pho.2012.3225","article-title":"Antimicrobial Photodynamic Therapy in the Treatment of Oral Candidiasis in HIV-Infected Patients. Photomed","volume":"30","author":"Scwingel","year":"2012","journal-title":"Laser Surg."},{"key":"ref_40","first-page":"1311","article-title":"Therapy for oropharyngeal candidiasis in HIV-infected patients: A randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. The Multicenter Study Group","volume":"6","author":"Pons","year":"1993","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/030006059802600307","article-title":"Safety and Efficacy of Single-Dose Fluconazole Compared with a 7-Day Regimen of Itraconazole in the Treatment of AIDS-Related Oropharyngeal Candidiasis","volume":"26","author":"Clumeck","year":"1998","journal-title":"J. Int. Med. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/516342","article-title":"A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS","volume":"26","author":"Phillips","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/00002030-199111000-00014","article-title":"Itraconazole versus Ketaconazole in the Treatment of Oral and Oesophageal Candidosis in Patients Infected with HIV","volume":"5","author":"Smith","year":"1991","journal-title":"AIDS"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0149-2918(97)80131-2","article-title":"Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients","volume":"19","author":"Murray","year":"1997","journal-title":"Clin. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1365-4362.2000.00087.x","article-title":"Clinical trial: Clotrimazole troche vs. itraconazole oral solution in the treatment of oral candidosis in AIDS patients","volume":"39","author":"Linpiyawan","year":"2000","journal-title":"Int. J. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1093\/infdis\/168.5.1332","article-title":"Single-Dose versus 7 Days of Fluconazole Treatment for Oral Candidiasis in Human Immunodeficiency Virus-Infected Patients: A Prospective, Randomized Pilot Study","volume":"168","author":"Goossens","year":"1993","journal-title":"J. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1086\/592578","article-title":"Single-Dose Fluconazole versus Standard 2-Week Therapy for Oropharyngeal Candidiasis in HIV-Infected Patients: A Randomized, Double-Blind, Double-Dummy Trial","volume":"47","author":"Hamza","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00002030-199706000-00009","article-title":"A dose comparison study of a new triazole antifungal (D0870) in HIV-positive patients with oral candidiasis","volume":"11","author":"Dupont","year":"1997","journal-title":"AIDS"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1310\/hct1104-186","article-title":"Randomized, Comparative, Double-Blind, Double-Dummy, Multicenter Trial of Miconazole Buccal Tablet and Clotrimazole Troches for the Treatment of Oropharyngeal Candidiasis: Study of Miconazole Lauriad\u00ae Efficacy and Safety (SMiLES)","volume":"11","author":"Vazquez","year":"2010","journal-title":"HIV Clin. Trials"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1086\/513664","article-title":"Oropharyngeal Candidiasis in Patients with AIDS: Randomized Comparison of Fluconazole Versus Nystatin Oral Suspensions","volume":"24","author":"Pons","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Vazquez, J.A., and Zawawi, A.A. (2002). Efficacy of alcohol-based and alcohol-free melaleuca oral solution for the treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS. HIV Clin. Trials, 3.","DOI":"10.1310\/99DY-8Q52-306A-V0AJ"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00126334-200402010-00007","article-title":"Comparative Efficacy of Topical Therapy with a Slow-Release Mucoadhesive Buccal Tablet Containing Miconazole Nitrate versus Systemic Therapy with Ketoconazole in HIV-Positive Patients with Oropharyngeal Candidiasis","volume":"35","author":"Kamya","year":"2004","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/QAD.0000000000001286","article-title":"Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants","volume":"31","author":"Mukherjee","year":"2017","journal-title":"AIDS"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.phymed.2008.07.015","article-title":"Treatment of oral thrush in HIV\/AIDS patients with lemon juice and lemon grass (Cymbopogon citratus) and gentian violet","volume":"16","author":"Wright","year":"2009","journal-title":"Phytomedicine"},{"key":"ref_55","first-page":"CD003940","article-title":"Interventions for the Prevention and Management of Oropharyngeal Candidiasis Associated with HIV Infection in Adults and Children","volume":"11","author":"Pienaar","year":"2010","journal-title":"Cochrane Database Syst. Rev. Online"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1067\/moe.2001.116600","article-title":"A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients","volume":"92","author":"Patton","year":"2001","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2165\/00003495-199550040-00007","article-title":"Fluconazole","volume":"50","author":"Goa","year":"1995","journal-title":"Drugs"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1093\/clinids\/14.Supplement_1.S161","article-title":"Azole Antifungal Agents","volume":"14","author":"Bodey","year":"1992","journal-title":"Clin. Infect. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2165\/00003088-199733010-00005","article-title":"Clinical Pharmacokinetics of Fluconazole in Superficial and Systemic Mycoses","volume":"33","author":"Debruyne","year":"1997","journal-title":"Clin. Pharmacokinet."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/HIV.S6660","article-title":"Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection","volume":"2","author":"Vazquez","year":"2010","journal-title":"HIV\/AIDS Res. Palliat. Care"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3389\/fmicb.2015.01391","article-title":"Clinical Appearance of Oral Candida Infection and Therapeutic Strategies","volume":"6","author":"Patil","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref_62","first-page":"45","article-title":"Role of Posaconazole in the Treatment of Oropharyngeal Candidiasis","volume":"3","author":"Ianas","year":"2010","journal-title":"Infect. Drug Resist."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Shuster, S. (1999). The Safety Aspects of Systemic and Topical Antifungal Agents Used in the Management of Onychomycosis. Hydroxy-Pyridones as Antifungal Agents with Special Emphasis on Onychomycosis, Springer.","DOI":"10.1007\/978-3-642-58401-5"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1128\/AAC.01657-09","article-title":"Systematic Review and Meta-Analysis of the Tolerability and Hepatotoxicity of Antifungals in Empirical and Definitive Therapy for Invasive Fungal Infection","volume":"54","author":"Wang","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_65","first-page":"20","article-title":"Epidemiology of Oropharyngeal Candidiasis in Human Immunodeficiency Virus\/Acquired Immune Deficiency Syndrome Patients and CD4+ Counts","volume":"7","author":"Berberi","year":"2015","journal-title":"J. Int. Oral Health"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/jac\/dkq136","article-title":"Candidaemia associated with decreased in vitro fluconazole susceptibility: Is Candida speciation predictive of the susceptibility pattern?","volume":"65","author":"Oxman","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archinte.169.4.379","article-title":"Risk Factors for Fluconazole-Resistant Candida glabrata Bloodstream Infections","volume":"169","author":"Lee","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1080\/13693780802354037","article-title":"National surveillance of antifungal susceptibility of Candida species in South Korean hospitals","volume":"47","author":"Yoo","year":"2009","journal-title":"Med. Mycol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3109\/00365548.2014.900190","article-title":"Fungemia in a Spanish hospital: The role of Candida parapsilosis over a 15-year period","volume":"46","author":"Carrizosa","year":"2014","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.ajic.2015.11.028","article-title":"Invasive candidiasis in intensive care units in China: Risk factors and prognoses of Candida albicans and non\u2013albicans Candida infections","volume":"44","author":"Gong","year":"2016","journal-title":"Am. J. Infect. Control."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/jac\/dkl241","article-title":"Effect of fluconazole consumption on long-term trends in can-didal ecology","volume":"58","author":"Blot","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_72","first-page":"e172","article-title":"Therapeutic tools for oral can-didiasis: Current and new antifungal drugs","volume":"24","author":"Sevillano","year":"2019","journal-title":"Med. Oral Patol. Oral Cir. Bucal."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1128\/CDLI.6.6.921-923.1999","article-title":"Successful Treatment of Fluconazole-Resistant Oropharyngeal Candidiasis by a Combination of Fluconazole and Terbinafine","volume":"6","author":"Ghannoum","year":"1999","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1128\/AAC.39.9.1907","article-title":"Use of amphotericin B with azole antifungal drugs: What are we doing?","volume":"39","author":"Sugar","year":"1995","journal-title":"Antimicrob. Agen. Chemother."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/423378","article-title":"A Randomized, Double-Blind Trial of Anidulafungin versus Fluconazole for the Treatment of Esophageal Candidiasis","volume":"39","author":"Krause","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0002-9343(02)01191-9","article-title":"A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis","volume":"113","author":"Villanueva","year":"2002","journal-title":"Am. J. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1086\/323401","article-title":"A Randomized Double-Blind Study of Caspofungin versus Amphotericin for the Treatment of Candidal Esophagitis","volume":"33","author":"Villanueva","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1128\/AAC.46.6.1773-1780.2002","article-title":"Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins","volume":"46","author":"Kuhn","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1128\/AAC.46.11.3591-3596.2002","article-title":"In Vitro Activity of Caspofungin against Candida albicans Biofilms","volume":"46","author":"Bachmann","year":"2002","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/7\/8\/637\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:40:56Z","timestamp":1760164856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/7\/8\/637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,5]]},"references-count":80,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["jof7080637"],"URL":"https:\/\/doi.org\/10.3390\/jof7080637","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,5]]}}}